D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
1701
DELISTED
Premier
PINC
| $3.35M | 0.01% |
102,536
-94,600
| -48% | -$3.09M |
|
|
NVMI
1702
Nova
NVMI
$13.6B
| $3.34M | 0.01% |
102,433
-34,652
| -25% | -$1.26M |
|
|
IVC
1703
DELISTED
Invacare Corporation
IVC
| $3.34M | 0.01% |
449,925
-388,893
| -46% | -$3.01M |
|
|
ROIC
1704
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.34M | 0.01% |
402,991
+351,016
| +675% | +$5.22M |
|
1705
CALL
Stryker
SYK
$129B
| $3.33M | 0.01% |
20,000
-4,100
| -17% | -$801K |
|
1706
CALL
T. Rowe Price
TROW
$25.5B
| $3.32M | 0.01% |
34,000
-2,300
| -6% | -$282K |
|
1707
Huntington Ingalls Industries
HII
$11.4B
| $3.31M | 0.01% |
18,186
-9,664
| -35% | -$2.25M |
|
1708
Colliers International
CIGI
$5.21B
| $3.31M | 0.01% |
69,200
-35,600
| -34% | -$2.67M |
|
1709
PUT
Lumen
LUMN
$6.45B
| $3.31M | 0.01% |
350,000
-20,100
| -5% | -$251K |
|
1710
CALL
C.H. Robinson
CHRW
$20.6B
| $3.31M | 0.01% |
50,000
+40,000
| +400% | +$2.87M |
|
1711
Bio-Rad Laboratories Class A
BIO
$8.47B
| $3.31M | 0.01% |
9,428
-3,146
| -25% | -$1.16M |
|
1712
PUT
HP
HPQ
$24.3B
| $3.3M | 0.01% |
190,000
-20,800
| -10% | -$421K |
|
1713
PUT
Novartis
NVS
$297B
| $3.3M | 0.01% |
40,000
-1,100
| -3% | -$98.1K |
|
1714
NovoCure
NVCR
$1.97B
| $3.29M | 0.01% |
48,921
-57,392
| -54% | -$4.54M |
|
1715
PUT
Southwest Airlines
LUV
$22.2B
| $3.27M | 0.01% |
91,900
-63,900
| -41% | -$3.17M |
|
1716
PUT
Everest Group
EG
$15.4B
| $3.27M | 0.01% |
17,000
+12,700
| +295% | +$3.24M |
|
1717
Digital Realty Trust
DLR
$72.4B
| $3.27M | 0.01% |
23,515
+10,081
| +75% | +$1.28M |
|
1718
BridgeBio Pharma
BBIO
$16.5B
| $3.27M | 0.01% |
+112,589
| New | +$3.49M |
|
1719
The Bancorp
TBBK
$2.81B
| $3.26M | 0.01% |
536,973
-172,231
| -24% | -$1.84M |
|
|
NUVA
1720
DELISTED
NuVasive, Inc.
NUVA
| $3.26M | 0.01% |
64,269
-17,719
| -22% | -$1.19M |
|
1721
Alexandria Real Estate Equities
ARE
$8.96B
| $3.25M | 0.01% |
+23,748
| New | +$3.72M |
|
|
FBC
1722
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.25M | 0.01% |
164,023
+9,043
| +6% | +$293K |
|
|
THCAU
1723
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
| $3.25M | 0.01% |
325,000
| – | – |
|
1724
PUT
BorgWarner
BWA
$13.1B
| $3.25M | 0.01% |
151,429
+86,450
| +133% | +$2.5M |
|
1725
CALL
Franco-Nevada
FNV
$41.4B
| $3.24M | 0.01% |
32,600
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.